Evidence map›Paper›PMID 34666677›Full record

ArticleBMC bioinformatics2021

Improved detection of disease-associated gut microbes using 16S sequence-based biomarkers.

Brianna S Chrisman, Kelley M Paskov, Nate Stockham, Jae-Yoon Jung, Maya Varma, Peter Y Washington, Christine Tataru, Shoko Iwai, Todd Z DeSantis, Maude David and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Diversity and functional prediction of gut microbiota in children with autism spectrum disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Brianna S ChrismanDepartment of Bioengineering, Stanford University, Serra Mall, Stanford, USA. briannac@stanford.edu.ORCID http://orcid.org/0000-0002-7157-607X
Kelley M PaskovDepartment of Biomedical Data Science, Stanford University, Serra Mall, Stanford, USA.
Nate StockhamDepartment of Neuroscience, Stanford University, Serra Mall, Stanford, USA.
Jae-Yoon JungDepartment of Biomedical Data Science, Stanford University, Serra Mall, Stanford, USA.
Maya VarmaDepartment of Computer Science, Stanford University, Serra Mall, Stanford, USA.
Peter Y WashingtonDepartment of Bioengineering, Stanford University, Serra Mall, Stanford, USA.
Christine TataruDepartment of Computer Science, Oregon State University, SW Campus Way, Corvallis, USA.
Shoko IwaiSecond Genome Inc, Allerton Ave, Brisbane, USA.
Todd Z DeSantisSecond Genome Inc, Allerton Ave, Brisbane, USA.
Maude DavidDepartment of Microbiology, Oregon State University, SW Campus Way, Corvallis, USA.
Dennis P WallDepartment of Biomedical Data Science, Stanford University, Serra Mall, Stanford, USA.
Stanford University · USOregon State University · USSecond Genome (United States) · US

Funding

Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS DisordersR44DA043954 · NIDA · SECOND GENOME, INC. · PI DESANTIS, TODD Z · 2017 to 2020
$2.1M
National Science Foundation GRFPNIDA NIH HHS R44 DA043954NIDA NIH HHS R44DA04395402Stanford University Stanford Bio-X
6 · The paper itself

Abstract

backgroundSequencing partial 16S rRNA genes is a cost effective method for quantifying the microbial composition of an environment, such as the human gut. However, downstream analysis relies on binning reads into microbial groups by either considering each unique sequence as a different microbe, querying a database to get taxonomic labels from sequences, or clustering similar sequences together. However, these approaches do not fully capture evolutionary relationships between microbes, limiting the ability to identify differentially abundant groups of microbes between a diseased and control cohort. We present sequence-based biomarkers (SBBs), an aggregation method that groups and aggregates microbes using single variants and combinations of variants within their 16S sequences. We compare SBBs against other existing aggregation methods (OTU clustering and Microphenoor DiTaxa features) in several benchmarking tasks: biomarker discovery via permutation test, biomarker discovery via linear discriminant analysis, and phenotype prediction power. We demonstrate the SBBs perform on-par or better than the state-of-the-art methods in biomarker discovery and phenotype prediction.

resultsOn two independent datasets, SBBs identify differentially abundant groups of microbes with similar or higher statistical significance than existing methods in both a permutation-test-based analysis and using linear discriminant analysis effect size. . By grouping microbes by SBB, we can identify several differentially abundant microbial groups (FDR <.1) between children with autism and neurotypical controls in a set of 115 discordant siblings. Porphyromonadaceae, Ruminococcaceae, and an unnamed species of Blastocystis were significantly enriched in autism, while Veillonellaceae was significantly depleted. Likewise, aggregating microbes by SBB on a dataset of obese and lean twins, we find several significantly differentially abundant microbial groups (FDR<.1). We observed Megasphaera andSutterellaceae highly enriched in obesity, and Phocaeicola significantly depleted. SBBs also perform on bar with or better than existing aggregation methods as features in a phenotype prediction model, predicting the autism phenotype with an ROC-AUC score of .64 and the obesity phenotype with an ROC-AUC score of .84.

conclusionsSBBs provide a powerful method for aggregating microbes to perform differential abundance analysis as well as phenotype prediction. Our source code can be freely downloaded from http://github.com/briannachrisman/16s_biomarkers .

Indexed as

Gastrointestinal MicrobiomeBiomarkersCluster AnalysisHumansRNA, Ribosomal, 16SSoftwareBiomarkersRNA, Ribosomal, 16S16SGenomicsMicrobiome

Identifiers

PMID34666677
PMCPMC8527694
OpenAlexW3207816521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.